RegeneRx Biopharmaceuticals, Inc. - Enterprise Value

The Enterprise Value as of July 2026 (TTM) for RegeneRx Biopharmaceuticals, Inc. (RGRX) is 1.16M

According to RegeneRx Biopharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.16M. This represents a change of -99.94% compared to the average of 1.93B of the last 4 quarters.

RegeneRx Biopharmaceuticals, Inc. (RGRX) Historical Enterprise Value (quarterly & annually)

How has RGRX Enterprise Value performed in the past?

The mean historical Enterprise Value of RegeneRx Biopharmaceuticals, Inc. over the last ten years is 2.58B. The current 1.16M Enterprise Value has changed -95.53% with respect to the historical average. Over the past ten years (40 quarters), RGRX's Enterprise Value was at its highest in in the March 2016 quarter at 7.10B. The Enterprise Value was at its lowest in in the December 2013 quarter at 437.70M.

RegeneRx Biopharmaceuticals, Inc. (RGRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of RegeneRx Biopharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

RegeneRx Biopharmaceuticals, Inc. (RGRX) Average Enterprise Value

How has RGRX Enterprise Value performed in the past?

The current Enterprise Value of RegeneRx Biopharmaceuticals, Inc. (RGRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

RegeneRx Biopharmaceuticals, Inc. (RGRX) Enterprise Value vs. Peers

How is RGRX’s Enterprise Value compared to its peers?

RegeneRx Biopharmaceuticals, Inc.’s Enterprise Value is less than BioSyntech, Inc. (8.60M), greater than Nascent Biotech, Inc. (-146290.00), less than Hemagen Diagnostics, Inc. (4.96M), less than ChitogenX Inc. (4.26M), greater than Qrons Inc. (495.14K), greater than Quantum Medical Transport, Inc. (25.04K), greater than ViaDerma, Inc. (806.18K), less than 4Front Ventures Corp. (206.45M), greater than Actavia Life Sciences, Inc. (521.89K), less than Forza Innovations Inc. (2.06M),

Build a custom stock screener for RegeneRx Biopharmaceuticals, Inc. (RGRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RegeneRx Biopharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RegeneRx Biopharmaceuticals, Inc. (RGRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RegeneRx Biopharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.